ABT vs SPIR · P/E 25, rev $44.33B vs rev $110.5M
Abbott Laboratories (ABT) versus Spire Global Inc (SPIR) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Spire Global Inc (SPIR) is a specialty business services company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported SPIR revenue for 2024-12-31 was $110.5M. Net income was -$102.8M. Revenue was up 13.2% from 2023-12-31 to 2024-12-31. SPIR currently screens at market cap $351.2M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. SPIR currently screens at market cap $351.2M.
Not investment advice. Open the ABT and SPIR stock pages for the full models.
Not investment advice.